KIORA PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
KIORA PHARMACEUTICALS, INC. (KPRX) reported Earnings Per Share, Basic and Diluted of -$0.35 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-12
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.35.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.37.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.44.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.38.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.77.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.23.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$4.57.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.93.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.35 10-Q · filed 2021-08-12 | -$0.72 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | -$0.37 10-Q · filed 2021-05-12 | |||||||
| 2020-12-31 | -$1.77 10-K · filed 2021-03-25 | |||||||
| 2020-09-30 | -$0.44 10-Q · filed 2020-11-09 | -$1.25 10-Q · filed 2020-11-09 | ||||||
| 2020-06-30 | -$0.38 10-Q · filed 2021-08-12 | -$0.81 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$0.43 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | -$2.23 10-K · filed 2021-03-25 | |||||||
| 2019-09-30 | -$1.15 10-Q · filed 2020-11-09 | -$1.47 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | -$0.63 10-Q · filed 2020-08-06 | -$0.04 10-Q · filed 2019-08-08 | -$0.33 10-Q · filed 2020-08-06 | -$0.02 10-Q · filed 2019-08-08 | ||||
| 2018-12-31 | -$4.57 10-K · filed 2020-03-04 | -$0.30 10-K · filed 2019-03-01 | ||||||
| 2018-09-30 | -$1.08 10-Q · filed 2019-11-07 | -$0.07 10-Q · filed 2018-11-13 | -$3.80 10-Q · filed 2019-11-07 | -$0.25 10-Q · filed 2018-11-13 | ||||
| 2018-06-30 | -$0.07 10-Q · filed 2019-08-08 | -$0.19 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | -$0.14 10-Q · filed 2018-05-11 | |||||||
| 2017-12-31 | -$0.93 10-K · filed 2019-03-01 | |||||||
| 2017-09-30 | -$0.24 10-Q · filed 2018-11-13 | -$0.51 derived: net income ÷ weighted average shares · filed 2018-11-13 | -$0.78 10-Q · filed 2018-11-13 | -$1.14 derived: net income ÷ weighted average shares · filed 2018-11-13 | ||||
| 2017-06-30 | -$0.28 10-Q · filed 2018-08-03 | -$0.55 10-Q · filed 2018-08-03 | -$0.92 derived: net income ÷ weighted average shares · filed 2018-08-03 | -$1.28 derived: net income ÷ weighted average shares · filed 2018-08-03 | ||||
| 2017-03-31 | -$0.28 10-Q · filed 2018-05-11 | -$0.65 derived: net income ÷ weighted average shares · filed 2018-05-11 | -$1.01 derived: net income ÷ weighted average shares · filed 2018-05-11 | -$1.46 derived: net income ÷ weighted average shares · filed 2018-05-11 | ||||
| 2016-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2018-03-02 | -$0.74 derived: net income ÷ weighted average shares · filed 2018-03-02 | -$1.19 derived: net income ÷ weighted average shares · filed 2018-03-02 | -$1.51 10-K · filed 2017-02-23 | ||||
| 2016-09-30 | -$0.36 10-Q · filed 2017-11-14 | -$0.82 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$1.13 10-Q · filed 2017-11-14 | -$1.49 derived: net income ÷ weighted average shares · filed 2017-11-14 | ||||
| 2016-06-30 | -$0.46 10-Q · filed 2017-08-04 | -$0.77 10-Q · filed 2017-08-04 | -$1.12 derived: net income ÷ weighted average shares · filed 2017-08-04 | -$1.33 derived: net income ÷ weighted average shares · filed 2017-08-04 | ||||
| 2016-03-31 | -$0.31 10-Q · filed 2017-05-05 | -$0.66 derived: net income ÷ weighted average shares · filed 2017-05-05 | -$0.86 derived: net income ÷ weighted average shares · filed 2017-05-05 | -$1.11 derived: net income ÷ weighted average shares · filed 2017-05-05 | ||||
| 2015-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$0.55 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$0.79 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.70 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | -$0.19 10-Q · filed 2016-11-01 | -$0.43 derived: net income ÷ weighted average shares · filed 2016-11-01 | -$2.46 10-Q · filed 2016-11-01 | -$3.35 derived: net income ÷ weighted average shares · filed 2016-11-01 | ||||
| 2015-06-30 | -$0.24 10-Q · filed 2016-08-10 | -$2.57 10-Q · filed 2016-08-10 | -$3.90 derived: net income ÷ weighted average shares · filed 2016-08-10 | -$4.98 derived: net income ÷ weighted average shares · filed 2016-08-10 | ||||
| 2015-03-31 | -$3.23 10-Q · filed 2016-05-13 | -$6.33 derived: net income ÷ weighted average shares · filed 2016-05-13 | -$8.76 derived: net income ÷ weighted average shares · filed 2016-05-13 | -$11.85 derived: net income ÷ weighted average shares · filed 2016-05-13 | ||||
| 2014-12-31 | -$2.08 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.54 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$4.21 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$9.20 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $1.59 10-Q · filed 2015-11-12 | -$2.09 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$7.13 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$3.82 10-Q · filed 2015-08-12 | -$9.04 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$0.47 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |